Target intelligence / Profile preview

RNA, U6 small nuclear 1275, pseudogene (RNU6-1275P)

Target: RNU6-1275P
Molecular classification: Pseudogene, Non-coding RNA, Small nuclear RNA (snRNA) pseudogene

Overview

**RNA, U6 small nuclear 1275, pseudogene (RNU6-1275P)** is a human pseudogene related to the U6 small nuclear RNA family[1]. The canonical U6 small nuclear RNAs are essential components of the spliceosome complex, where they play a central catalytic role in pre-mRNA splicing, but RNU6-1275P is a pseudogene and does not produce a functional U6 snRNA[1][3][4]. Pseudogenes such as RNU6-1275P are typically non-functional gene copies generated by gene duplication or retrotransposition, and most do not encode functional products. Some pseudogenes may, in rare instances, have regulatory RNA functions (such as microRNA "sponging" or gene regulation at the RNA level), but there is no evidence that RNU6-1275P has any such function or relevance in disease, biomarker selection, or therapeutic targeting[2]. RNU6-1275P is not considered a therapeutic target and is not associated with any known safety or biomarker concerns[1].

Other names: RNU6-1275PRNA, U6 small nuclear 1275 pseudogene

Mechanism of action

None applicable

Biological functions

None (for this specific pseudogene); general functions of related pseudogene transcripts may include acting as competing endogenous RNAs, miRNA decoys, or antisense regulators in rare cases

Disease associations

None known for RNU6-1275P specifically; other pseudogenes may play roles in cancer and other diseases through RNA regulatory mechanisms

Beyond the preview

Go deeper on RNA, U6 small nuclear 1275, pseudogene (RNU6-1275P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1275, pseudogene (RNU6-1275P).

Explore the full profile